The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Abstract
BACKGROUND Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. METHODS We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11 022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. FINDINGS Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11.0-21.2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%, 16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3.0 million (range 0.8-6.6 million) people who inject drugs might be HIV positive. INTERPRETATION The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,970
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Review of sampling hard-to-reach and hidden populations for HIV surveillance
Magnani, R., Sabin, K., Saidel, T., & Heckathorn, D. (2005) · AIDS · doi:10.1097/01.aids.0000172879.20628.e1 · Cited by 1,043
Health metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Global overview of injecting drug use and HIV infection among injecting drug users
Aceijas, C., Stimson, G. V., Hickman, M., & Rhodes, T. (2004) · AIDS · doi:10.1097/00002030-200411190-00010 · Cited by 444
Self-citationThe spread and effect of HIV-1 infection in sub-Saharan Africa
Buvé, A., Bishikwabo-Nsarhaza, K., & Mutangadura, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08823-2 · Cited by 298
Oslo Ministerial Declaration—global health: a pressing foreign policy issue of our time
Ministers of Foreign Affairs of Brazil, F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60498-x · Cited by 281
Brosnan, C. A., Brosnan, P., Therrell, B. L., Slater, C. H., Swint, J. M., Annegers, J. F., & Riley, W. J. (1998) · Europe PMC (PubMed Central) · Cited by 194
How many dependent heroin users are there in Australia?
Hall, W. D., Ross, J. E., Lynskey, M. T., Law, M. G., & Degenhardt, L. J. (2000) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb139321.x · Cited by 172
Self-citationSloboda, Z. (2005) · Springer eBooks · doi:10.1007/b105372 · Cited by 80
p16INK4A and p14ARF tumour suppressors in melanoma: lessons from the mouse
Walker, G. J., & Hayward, N. K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07271-9 · Cited by 41
Sendziuk, P. (2007) · Canadian Journal of Health History · doi:10.3138/cbmh.24.1.113 · Cited by 20
Cited by
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Self-citationGlobal epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30375-3 · Cited by 1,429
Self-citationExtent of illicit drug use and dependence, and their contribution to the global burden of disease
Degenhardt, L., & Hall, W. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61138-0 · Cited by 1,303
Self-citationNelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Self-citation
Metadata
- Authors
- Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., & Mattick, R. P.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 372
- Issue
- 9651
- Pages
- 1733-1745
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2133039181
- Cited by
- 1,285
- References
- 13
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.